Steris (India) Profile
Key Indicators
- Authorised Capital ₹ 2.20 Cr
- Paid Up Capital ₹ 1.07 Cr
- Company Age 19 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 46.15%
- Profit Growth 139.37%
- Ebitda 121.78%
- Net Worth 46.25%
- Total Assets -11.50%
About Steris (India)
Steris (India) Private Limited (SIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 29 June 2005 and has a history of 19 years and seven months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.20 Cr and a paid-up capital of Rs 1.07 Cr, as per Ministry of Corporate Affairs (MCA) records.
Krishna Singh, Vikas Gaikwad, Nitesh Piplani, and One other member serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33112MH2005PTC282545
-
Company No.
282545
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Jun 2005
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Steris (India)?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Patrick Dobbins
|
Additional Director | 15-Jan-2019 | Current |
Krishna Singh
|
Director | 29-Oct-2012 | Current |
|
Vikas Gaikwad
|
Director | 24-Aug-2018 | Current |
|
Nitesh Piplani
|
Director | 21-Mar-2022 | Current |
Financial Performance of Steris (India).
Steris (India) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 46.15% increase. The company also saw a substantial improvement in profitability, with a 139.37% increase in profit. The company's net worth Soared by an impressive increase of 46.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Steris (India)?
In 2022, Steris (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Medical Technology Association Of IndiaNitesh Piplani is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Steris (India)?
Steris (India) has a workforce of 74 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Steris (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Steris (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
